Christopher Frankenfield

Christopher Frankenfield serves as Chief Financial Officer and Chief Operating Officer at Xilio Therapeutics, Inc.. Xilio Therapeutics, Inc. operates in the research sector with approximately 79.0 employees. Xilio Therapeutics, Inc. generates annual revenue of 6344000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • Our database includes 201,469 c suite-level executives.

Route 53 Outlook Google Cloud Hosting Akamai RUM Mobile Friendly Google Analytics WordPress.org New Relic Google Tag Manager Nginx Bootstrap Framework Remote AI

biotechnology immunotherapeutics cancer biotechnology: pharmaceutical preparations health care biotechnology research tumor-selective immunotherapy anti-ctla-4 il-12 tumor-activated therapies solid tumors biologics cytokines antibodies clinical development preclinical development therapeutic index localized treatment tumor microenvironment immune-modulatory molecules gps platform fc-enhanced antibodies tolerability anti-tumor activity checkpoint inhibition monoclonal antibodies cell engagers syngeneic models therapeutic options biopharmaceutical drug discovery phase 1 clinical trials anti-pd-1 novel therapies treatment resistance first-in-human studies clinical validation reproducibility matrix metalloproteases (mmps) systemic side effects effective treatments cancer diagnostics research & development targeted delivery cancer immunotherapeutics tumor-selective activity innovative molecules clinical outcomes radionuclide therapy tumor-activated immuno-oncology precision immunotherapy cancer treatment tumor-selective therapies masked bispecifics t cell engagers proprietary platform technology clinical-stage biotechnology hematologic malignancies immune system activation systemic toxicity reduction investigational therapies fc-enhanced monoclonal antibodies il-2 engineered il-12 cancer patient outcomes oncology research targeted therapeutic innovation biotechnology sector immunotherapy pipeline patient-centric cancer treatment collaboration with abbvie advanced solid tumors colorectal cancer prostate cancer lung cancer matrix metalloproteases clinical trials cancer immunotherapy health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Christopher Frankenfield in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Xilio Therapeutics, Inc..

Christopher Frankenfield's Position in the MessageCEO Database

• •Christopher Frankenfield is 1 of 1 verified executive contact we track at Xilio Therapeutics, Inc..
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •9 verified contacts work at research companies in the 79.0 employee range (same size as Xilio Therapeutics, Inc.).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Christopher Frankenfield directly?

Christopher Frankenfield's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Financial Officer and Chief Operating Officer at Xilio Therapeutics, Inc.. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Christopher Frankenfield work for?

Christopher Frankenfield is Chief Financial Officer and Chief Operating Officer at Xilio Therapeutics, Inc., a company in the research sector with 79.0 employees.

Can I pitch or sell to Christopher Frankenfield?

As Chief Financial Officer and Chief Operating Officer at Xilio Therapeutics, Inc., Christopher Frankenfield is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Christopher Frankenfield directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Christopher Frankenfield in?

Christopher Frankenfield works in the research industry as Chief Financial Officer and Chief Operating Officer at Xilio Therapeutics, Inc.. MessageCEO provides verified contact information for executives across all major industries.

Is Christopher Frankenfield's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Christopher Frankenfield's profile is kept up-to-date with the latest available information.

Last updated: June 21, 2026